Cansortium (OTCMKTS:CNTMF – Get Free Report) released its earnings results on Thursday. The company reported ($0.16) earnings per share (EPS) for the quarter, RTT News reports. During the same quarter in the previous year, the firm posted ($0.14) EPS.
Cansortium Price Performance
Shares of CNTMF stock traded down $0.00 during trading hours on Friday, hitting $0.03. 614,058 shares of the company’s stock traded hands, compared to its average volume of 338,210. The stock’s fifty day simple moving average is $0.03 and its two-hundred day simple moving average is $0.04. Cansortium has a 12-month low of $0.03 and a 12-month high of $0.09.
About Cansortium
Cansortium, Inc (OTCMKTS:CNTMF) is a vertically integrated cannabis company engaged in the cultivation, manufacturing, distribution and retail of medical cannabis products in the United States. The company’s operations span from seed to sale, with dedicated cultivation facilities, extraction labs and a network of dispensaries serving registered patients.
Cansortium holds licenses and operates in multiple jurisdictions, including Florida, Pennsylvania, Louisiana, Texas and Puerto Rico. Its product portfolio encompasses cannabis flower, pre-rolls, concentrates, vape cartridges, oils, edibles and topicals, offered under brands such as The+Source, Chroma and Campfire, alongside its private-label formulations.
Founded in 2017 and headquartered in Miami, Cansortium began dispensary operations in Florida in 2018 and has since expanded its footprint into new markets.
Featured Articles
Receive News & Ratings for Cansortium Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cansortium and related companies with MarketBeat.com's FREE daily email newsletter.
